Search for: "Anderson v. Eli Lilly "
Results 1 - 19
of 19
Sorted by Relevance
|
Sort by Date
14 May 2018, 12:30 pm
Birss would not be drawn on his views of the Supreme Court's decision in Eli Lilly v Actavis (see the IPKat here - the 109 comments on the post is a good indication of how controversial this decision has been). [read post]
1 Apr 2013, 9:11 pm
Eli Lilly and Co., 598 F.3d 1336 (Fed. [read post]
16 Mar 2020, 9:12 am
" Eli Lilly & Co. v. [read post]
7 Nov 2014, 5:52 am
Eli Lilly & Co., 394 F. [read post]
2 May 2011, 3:14 pm
Anderson v. [read post]
4 Jan 2013, 12:53 pm
Eli Lilly & Co., 2012 WL 6681895 (Mag. [read post]
22 Apr 2024, 5:00 am
Inst. v. [read post]
8 Oct 2015, 5:00 am
Eli Lilly & Co., 58 F. [read post]
10 Mar 2014, 11:31 am
Eli Lilly & Co., 504 F. [read post]
10 Jun 2011, 4:09 pm
" Anderson v. [read post]
22 Jan 2009, 2:06 am
Specifically as to inadequate warning claims the court in Anderson v. [read post]
25 Mar 2011, 8:29 pm
" Eli Lilly & Co. v. [read post]
1 Feb 2007, 6:07 am
Eli Lilly & Co., 1420 A.2d 1305, 1320 (N.J. [read post]
18 Apr 2007, 10:06 pm
Eli Lilly & Co., 965 F. [read post]
30 Apr 2011, 5:22 am
” Eli Lilly & Co. v. [read post]
26 May 2015, 7:42 am
In the latter category we place Newman v. [read post]
21 Jul 2010, 4:33 am
Young's legal representative, Michael Anderson of Anderson & Loeb, scoffed at the countersuit. [read post]
29 Apr 2011, 1:03 pm
" Eli Lilly & Co. v. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]